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Clearance of Renin in Unanesthetized Rats: Effects of Chronic Lead Exposure. tiISER, J. A., 
VANDER, A. J., AND GERMAIN, C. L. (1983). Toxic01 Appl. Pharmacol. 69, 127-137. These 
experiments studied the influence of chronic lead exposure on the steady-state clearance of 
exogenous homologous renin in unanesthetized, unrestrained rats. Relative to time controls (TC), 
rats chronically exposed to 500 ppm lead in drinking water had significantly elevated basal plasma 
renin concentrations (PRC) (Pb = 12.0 + I.6 ng/ml/hr, TC = 7.6 f 0.8). During the infusion 
of homologous renin sufficient to increase plasma renin approximately IO-fold, the clearance of 
renin was not different between the two groups (after 60-min infusion, Pb = 16. I + I .8 ml/kg/ 
mm, TC = 15.9 ? 1.5). Rats exposed to 1000 ppm lead did not have higher PRCs than time 
controls (Pb = 10.9 f 2.2, TC = 9.2 + 1.8). The clearances of renin in these two groups were 
also not significantly different (Pb = 15.3 + 2.8, TC = 18.3 f 2.5). Renal renin concentrations 
were significantly elevated in the 500 ppm rats (Pb = 1426 + I IO ug&idney, TC = 1065 + 118) 
consistent with an increased basal renin secretion, but were not elevated in the IOOO-ppm rats. 
There were no significant differences in the clearances of sulfobromophthalein (BSP) between 
any of the groups. The renin infusion significantly reduced BSP clearance, but did so equally in 
all groups. It is concluded that in unanesthetized, unrestrained rats the clearance of renin is not 
altered by chronic lead exposure of either 500 or 1000 ppm and that increased secretion of renin 
accounts for the elevated basal PRC observed in rats exposed to the lower dose of lead. 
Acute exposure of rats and dogs to iv admin- 
istered lead is associated with an increase in 
plasma renin activity (PRA) (Goldman d al., 
198 1; Mouw et al., 1978). Chronic lead ex- 
posure (500 ppm in drinking water, started at 
5 to 6 weeks of age) also produces significant 
elevations of PRA and plasma renin concen- 
tration (PRC) in rats (Fleischer et al., 1980; 
Victery et al., 1982a), with no change in 
plasma angiotensinogen concentration. It has 
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been demonstrated that the increased PRA 
observed in dogs following acute administra- 
tion of lead is a result of decreased hepatic 
removal of renin with little or no change in 
renin secretion (Goldman et al., 198 1). Hence, 
it is possible that the increase in PRC ob- 
served in the chronic lead-exposed rat is also 
due, at least in part, to a decreased rate of 
renin removal from plasma. 
We have recently tested this hypothesis in 
rabbits (Keiser et al., 1983) by determining 
the effects of chronic Pb exposure on the half- 
life of renin following nephrectomy. These 
data provided no evidence that renin clear- 
ance was altered by chronic lead exposure. 
However, these experiments were compli- 
cated by the fact that the Pb-exposed rabbits, 
unlike rats, failed to show a rise in PRA and 
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by the requirements for anesthesia, surgery, tained and any animal from whom a blood sample could 
nephrectomy, and non-steady-state condi- not be obtained was excluded from the experiment. Pre- 
tions. These are the usual methods for eval- vious pilot studies had demonstrated that, in hydrated 
uating renin clearance in small animals 
rats, by the first morning postsurgery. basal plasma renin 
was unchanged from that of unoperated animals. The 
(Christlieb et al., 1968; DeVito et al.. 1974; experiment consisted of a 90-min infusion period; rats 
Michelakis and Mizukoshi, 197 1; Schneider 
et al., 1970) despite evidence that these pro- 
cedures can profoundly lower hepatic blood 
flow (Bimie and Grayson, 1952) and that re- 
moval of renin by the liver accounts for vir- 
tually 100% of renin clearance (Heacox et al., 
1967; Horky et al., 1970). Therefore, the pres- 
ent experiments utilized unanesthetized, un- 
restrained rats and studied the steady-state 
clearance of homologous renin (achieved by 
renin infusions). The plasma concentrations 
of renin were sufficiently elevated to render 
trivial any contribution of endogenous renin 
secretion. 
METHODS 
All experiments were performed on adult male rats 
obtained from Charles River (Wilmington, Mass.). The 
animals were housed in a temperature-controlled room 
(24°C) on a fixed light schedule (0600-1800). They had 
free access to water and were fed ad libitum with a stan- 
dard rat chow (Purina Rat Chow, No. 5012). 
Protocol 1. Clearance of Renin in Chronically Lead-E-u- 
posed and Control Rats 
Series A. Thirty-six male rats (initially approximately 
150 g) were randomly divided into two treatment groups. 
The first group (n = 18) was given 500 ppm lead as lead 
acetate in the drinking water for 14-15 weeks, at which 
time clearance experiments were performed as described 
below. The second group of rats (n = 18) served as age- 
were unanesthetized and unrestrained in individual wire- 
floored cages during the protocol. Coiled connectors (PE- 
50 tubing) were attached to the venous and arterial cath- 
eters, allowing for the collection of blood samples without 
handling the animals. Blood samples (400 ~1) were ob- 
tained at 0, 30, 75, and 90 min via the arterial line, which 
was otherwise used for continuous pressure recording. Af- 
ter the initial (0) blood sample. an infusion of BSP (Sigma 
Chemical Co., St. Louis, MO., No. S 0252) was initiated. 
The priming dose of BSP was 17.5 mg/kg in 0.2 ml fol- 
lowed by a constant infusion of 0.63 mg/kg min given at 
0.02 ml/min with a Harvard infusion pump. After a 30- 
min blood sample for BSP clearance determination had 
been obtained, the BSP was continued and renin (semi- 
purified, homologous renin4) was begun (500 ppm rats 
and their time-controls received a priming dose of 12.4 
pg/kg and a constant infusion of 1240 ng/kg/min; IOOO- 
ppm rats and their controls received a priming dose of 
18.9 &kg and a constant infusion of 1890 ng/kg/min). 
Blood samples were obtained again at 75 and 90 min for 
determination of BSP and renin. In a fraction of the an- 
imals a sample was also obtained at 105 min. In four 
animals (two TC. two 500 ppm). after completion of the 
usual clearances, the infusion of renin was reduced by 
50%, and additional clearance measurements were made 
45 and 60 min later. In addition to BSP and renin. plasma 
angiotensin II (AU) was also measured in the final blood 
sample obtained in all experiments. 
At the completion of the clearance experiments ani- 
mals were killed by iv administration of 100 mg/kg so- 
dium pentobarbital. Both kidneys were rapidly excised. 
rinsed with ice-cold saline, dried. weighed, and frozen for 
later analysis. 
Protocol 2. Effects qf Renin Infitsion on the Clearance (11‘ 
BSP 
matched time-controls and drank tap water. Another study was performed on normal rats to ex- 
Series B. Twenty four male rats (initially approxi- amine the time course of the clearance of BSP with and 
mately 150 g) were randomly divided into two treatment without the additional infusion of renin. Fourteen male 
groups. The first group (n = 12) were given 1000 ppm rats (365 g) were randomly divided into two treatment 
lead as lead acetate in their drinking water for 15 to 16 groups. The clearance experiments were identical to those 
weeks. The second group (n = 12) served as time-controls described above except that the first group (n = 7) received 
and drank tap water. BSP infusions alone throughout the 90 min. The second 
The day before the clearance experiment was to be group (n = 7) received BSP for the first 30 min and BSP 
performed, each rat was anesthetized with sodium pen- with renin for an additional hour. Samples were collected 
tobarbital (50 mg/kg, ip). Heparinized catheters were in- as described above. 
serted into the left jugular vein and carotid artery for 
infusion and sampling, respectively; the catheters were 
exteriorized from the dorsal cervical region of the neck. 4 Semipurified rat renin was generously provided by 
The next morning patency of the catheters was ascer- Dr. Erwin Haas. 
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Protocol 3. Angiotensin II In&ion 
A necessary assumption made in our calculation of 
renin clearances was that the only source of renin in the 
rats during the protocol was the exogenous renin infused. 
As will be described below, the plasma concentrations of 
renin achieved were approximately IO-fold greater than 
basal concentrations so as to minimize the contribution 
of endogenous renin. Moreover. it was expected that en- 
dogenous renin would fall below basal concentrations 
during renin infusions, because AI1 is a potent inhibitor 
of renin secretion, and plasma AI1 concentrations were 
markedly elevated by the renin infusions. This assump- 
tion was tested by infusing AI1 into rats and measuring 
PRC. Three normal rats were instrumented as previously 
described. After baseline pressure recordings and blood 
samples had been obtained, the rats were infused with 
AI1 (Beckman: synthetic AII. lot No. 337707) at 15 ng/ 
kg/min; additional blood samples were obtained at 45 
and 60 min for measurement of PRC. Plasma AI1 con- 
centrations were measured on the 60-min sample. 
Analytical Methods 
Blood samples were collected in tubes containing 0.01 
ml of 0.2 M disodium ethylenediaminetetraacetate 
(NaEDTA): samples for measurement of AI1 were col- 
lected in an anticoagulant/inhibitor mixture containing 
0. I25 M NaEDTA and 0.025 M cFphenathroIIine in dis- 
tilled water with 0.2% neomycin sulfate. Samples were 
chilled, centrifuged, and separated at 4°C. and the plasma 
was frozen for subsequent analysis. 
Hematocrit was measured on a microhematocrit reader 
after centrifugation in a microcapillary centrifuge for 5 
min. Plasma Na+ and K’ concentrations were determined 
by flame photometry. Blood lead was measured by graph- 
ite furnace atomic absorption (Varian Instruments, Model 
375 CRA 90) by methods of addition. Standard spectro- 
photometric techniques were used to measure BSP (Se- 
ligson et al., 1957). with a modification for microsamples. 
AI1 was measured by direct radioimmunoassay of arterial 
plasma according to the methods of Nicholls and Espine? 
(1976). PRA was measured by radioimmunoassay of gen- 
erated angiotensin I with some modifications of a com- 
mercially available kit (New England Nuclear Corp., Bos- 
ton); the assay has been described in detail previously 
(Mouw et al.. 1978). Renal renin concentration was de- 
termined on homogenates of renal tissue after appropriate 
dilution and addition of substrate from 48-hr nephrec- 
tomized rat plasma. 
To make the calculation of renin clearance, it was nec- 
essary to convert PRA into PRC, since animals have a 
range of substrate concentrations (and, possibly, endog- 
’ The authors gratefully acknowledge the generous stock 
of AI1 antibody supplied to us by M. Gary Nicholls. 
enous inhibitors or activators of the reaction), which would 
contribute to variability in the measure of PRA at any 
given concentration of renin. Therefore, we converted 
activity to concentration in individual animals in the fol- 
lowing manner. First, a plasma renin “increment” was 
measured in at least one plasma sample from each rat by 
the addition of a standard amount of homologous renin 
to the samples; the additional amount of AI generated 
above baseline was labeled the increment. A mean value 
(x) for the increments was obtained for the group of rats. 
and the plasma renin concentration (PRC) for an indi- 
vidual rat (i) was calculated: 
PRC = PRA (Xincrement) 
(i Increment) 
The mean increment was also used to calculate the 
concentration of homologous renin given to the rats. The 
mean increments were similar in all groups of rats con- 
firming that lead does not alter the relationship between 
PRA and PRC (Fleischer et al., 1980: Mouw et al., 1978). 
The clearance of renin was calculated as the mass infused 
per minute divided by the PRC. and was expressed as 
ml/kg/min. The analogous formula was used to calculate 
the clearance of BSP. 
Statistical Analwis 
All group values are means + 1 SE. Student’s t test was 
used to test the difference between the two group means. 
A paired t test was used to compare data before and after 
treatments within a group. A p value less than 0.05 was 
accepted as significant. 
RESULTS 
Protocol I. Clearance of Renin in Chronically 
Lead-Exposed and Control Rats 
In rats chronically treated with 500 ppm 
lead, the basal PRC (obtained 30 min into the 
experiment) was approximately 60% higher 
than that of age-matched controls (Pb = 12.0 
k 1.6 ng/ml/hr, TC = 7.6 f. 0.8, p < .05). 
These data are depicted in Fig. 1 along with 
basal PRCs in the 1000-ppm rats and their 
controls. Although some of the rats treated 
with 1000 ppm lead had high basal PRCs, the 
mean value for the group was not significantly 
different from that of controls (Pb = 10.9 
k 2.2, TC = 9.2 f 1.8). 
Figure 2 depicts the PRCs achieved during 
the renin infusions in the two series. The renin 
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FIG. I. Effect of chronic lead exposure on basal plasma renin concentrations (PRC). The PRC was 
significantly elevated (p < 0.05) in rats exposed to 500 ppm lead in drinking water. 
infusions produced an 8- to 1 O-fold elevation The clearances of renin are depicted in Fig. 
in PRCs above basal levels. Values achieved 3; at no time were there any significant dif- 
for time-control and treatment groups were ferences between the lead-treated rats and their 
similar in both series. In a small number of time-control groups. The mean clearance was 
rats from each group, renin infusions were 14.7 +- 1.6 ml/kg/min in the 500 ppm rats at 
maintained for an additional 15 min, and these 75 min and 13.9 + 1.4 in the age-matched 
values are also shown in Fig. 2; it is clear that controls. Values for the lOOO-ppm rats and 
steady-state values for PRC have been time-controls at 75 min were 14.4 + 2.2 and 
achieved by 75 to 90 mins. 17.0 +- 2.6 ml/kg/min, respectively. The 90- 
A Pb 1000 ppm (n= 9) 
TIME (min.) 
FIG. 2. Plasma renin concentrations achieved during infusion of exogenous homologous renin. Renin 
infusions were initiated 30 min into the protocol. The IOOO-ppm rats and their time controls (TC, series 
B) received a 50% larger renin infusion than did the series A animals. In a fraction of the rats from each 
group, samples were also obtained at 105 min; therefore, the 90- and 105-min points are not connected. 
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FIG. 3. Clearance of renin in two series of chronically lead-exposed rats and time controls (TC). In a 
fraction of the rats from each group, clearances were also measured on samples obtained at 105 min; 
therefore, the 90- and 105min points are not connected. 
and 1 OS-min clearances were similar to values 
observed at 75 min. 
Clearances of BSP before and during renin 
infusions are shown in Fig. 4. The 500-ppm 
rats had average BSP clearances of 26.5 + 2.1 
ml/kg/min at 30 min; the controls averaged 
25.5 f 2.5. There was a significant drop in 
the clearance of BSP within each group be- 
P 
%-=i 
0 TC (n=l2) 0 TC In=91 
0 Pb 500 mm (n= 9) A Pb 1000 Wm h=8) 
tween 30 and 75 min, the values at 75 min 
being approximately 30% lower. There were 
no significant differences in the clearance of 
BSP between the two groups at any time dur- 
ing the experiment. The same pattern was seen 
for BSP clearance data from the lOOO-ppm 
rats and their controls, shown in Fig. 2B. 
Clearances ranged from 23 to 25 ml/kg/min 
t 3 
L 
I I I I , 1 
0 30 75 90 30 75 90 
TIME hin.1 TIME (min ) 
FIG. 4. Clearance of BSP before and during infusion of renin in two series of Pb-exposed and time- 
control (TC) rats. The clearance of BSP fell significantly within each group of rats between 30 and 75 min. 
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at 30 min, dropped approximately 35% in both 
groups between 30 and 75 min and remained 
stable throughout the remainder of the ex- 
periment. 
Plasma AI1 concentrations did not differ 
between the lead-treated groups and their 
controls: 500 ppm Pb = 162.7 ? 2 1.1 pg/ml, 
TC = 154.9 + 21.9; 1000 ppm Pb = 181.6 + 
13.6, TC = 157.2 + 17.6. Figure 5 depicts the 
correlation (? = 0.77) between plasma renin 
activity and AI1 concentrations from both 
control groups (pooled, n = 19); the blood 
samples were drawn at the end of the clear- 
ance experiments. (PRA, rather than PRC, 
was used for this correlation, since it is with 
activity rather than concentration that AI1 
should correlate best). The graph also in- 
cludes the 500- and lOOO-ppm rat data, which 
are not included in the calculation of the 
regression line. The slope of the regression 
line derived from control rat data is 1.63; those 
for the 500-ppm (? = 0.72, n = 14) and lOOO- 
ppm (r’ = 0.76, n = 9) rats yield slopes of 
1.49 and 1.10, respectively. It is clear from 
the figure that the points for the 500-ppm rats 
scatter along the regression line, whereas eight 
of the nine lOOO-ppm points fall below the 
control regression line. 
Renal renin concentrations in the four 
groups of rats are shown in Fig, 6. Rats chron- 
ically treated with 500 ppm lead had renal 
renin concentrations that were significantly 
different from their age matched controls 
(1426 + 110 vs 1065 5 118) (p < 0.05). The 
elevation in renin concentrations observed in 
the 500-ppm rats was not present at the lOOO- 
ppm dose; rats exposed to 1000 ppm lead had 
a mean renal renin concentration of 1089 
f 132 @g/kidney, whereas the control level 
was 1069 + 93. 
Blood lead, hematocrit, weight, and plasma 
electrolyte data from the four groups of rats 
are reported in Table 1. Blood lead concen- 
trations were 4 1.3 + 2.3 gg/dl in the 500-ppm 
rats and 54.9 + I .9 in the IOOO-ppm rats. 
Body weights were similar within each age- 
matched series. Kidney weights tended to be 
higher (although not significantly) in the 500- 
ppm rats compared to their controls, but the 
trend was not apparent at 1000 ppm lead. 
In four animals (two TC, two 500 ppm), 
after completion of the BSP and renin clear- 
ances, the infusion of renin was reduced by 
50% and additional clearance measurements 
were made 45 and 60 min later. In Fig. 7 the 
relationship between PRC and renin clear- 
500 - 
0 TC 
c 0 500ppm ^ 
P 
A 1000 ppm 
x TC y=l 66+163x 
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PLASMA RENIN ACTIVITY (ng Anpiotmsin I/ml/hr) 
FIG. 5. Correlation between plasma renin activity and angiotensin II concentration in time control (TC, 
pooled) and lead-exposed (500 and 1000 ppm) rats during renin infusion. The regression line was calculated 
only for the time-control animals. 
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FIG. 6. Effects of lead on renal renin concentration in two series of animals. Rats chronically exposed 
to 500 ppm lead had a significant elevation (p < .05) compared to time controls. 
antes is depicted for this group of four rats BSP at 75 min dropped significantly to 69.4 
and contrasted with data from the other rats + 3.1% of the baseline measured at 30 min. 
in that series (series A). The clearances of renin Rats receiving BSP alone also showed a fall 
were quite similar in the two groups despite in BSP clearance between 30 and 75 min, but 
a two-fold range of plasma renin concentra- of a much smaller magnitude; the value at 75 
tions. min was 87.3 + 5.8% of the baseline mea- 
surement; this value was significantly differ- 
Protocol 2. &feet of Renin Infusion on the ent from that of the renin-infused rats. 
Clearance if BSP 
Protocol 3. Angiotensin II Infusion 
The clearance of BSP was measured in a 
series of acute rats with and without the ad- Figure 8 depicts the PRCs in three rats be- 
ditional infusion of renin. In the group of rats fore and during constant infusions of AI1 (15 
that received renin and BSP, the clearance of ng/kg/min). The mean PRC at time zero was 
TABLE 1 
BLOOD LEAD, HEMATOCRIT, WEIGHTS, AND PLASMA ELECTROLYTES IN CHRONICALLY LEAD-TREATED RATS 
Dose of lead” added to drinking water 
Indices 
Series A Series B 
0 500 
(n = 9) (n = 12) (n ” 9) 
1000 
(n = 10) 
Blood [lead] (pg/dl) 2.2 f 0.5 41.3 rk 2.3 - 54.9 f 1.9 
Hematocrit (X 100) 44.1 f 1.4 42.8 -+ 1.3 42.3 f 0.7 40.5 f 1.6 
Body weight (g) 512.3 f 12.5 531.7 f 22.6 565.5 f 11.1 556.2 f 11.2 
Kidney weight (g) 1.66 k 0.07 1.86 k 0.07 1.79 f 0.07 1.76 + 0.04 
Plasma [Nat] (mM) 140.8 t 0.9 141.9 + 1.2 142.2 f 1.0 140.9 * 0.5 
Plasma [K+] (mM) 4.83 f 0.33 4.20 * 0.13 4.89 f 0.25 4.87 + 0.22 
Note. Values are mean f SE. -. Not measured. 
’ As lead acetate. 
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FIG. 7. Relationship between PRC and renin clearance. 
The group of animals with PRCs of 85 to 95 ng AI/ml/ 
hr represent the series A standard protocol. The second 
group of animals represent rats in which the renin infu- 
sion was reduced 50% for additional clearance measure- 
ments following the standard protocol. 
8.3 f 1.6 nglmlfhr and fell to 2.6 + 1.1 and 
2.1 + 0.7 ng/ml/hr at 45 and 60 min, re- 
spectively. The mean plasma AI1 concentra- 
tion measured for the group at 60 min was 
72.0 + 24.3 pg/ml, a value less than that pres- 
ent during the renin infusions of series A and 
B. Values for the individual animals are shown 
on the graph in parentheses. 
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FIG. 8. Plasma renin concentrations in three rats before 
and during constant infusions of AH. Plasma AU con- 
centrations (pg/ml) measured in the 60-min sample are 
shown in parentheses for the individual animals. 
DISCUSSION 
The hypothesis that rats chronically ex- 
posed to lead, beginning as young adults, have 
decreased metabolic clearance of renin was 
clearly not supported by the present experi- 
ments. As in previous studies (Fleischer el al., 
1980; Victery et al., 1982a). basal PRC in- 
creased significantly in the 500-ppm lead- 
treated rats compared to controls; however, 
clearances of renin from plasma, measured 
during steady-state infusions of homologous 
renin, were not different. Therefore, the ele- 
vation in PRC must be the result of increased 
renin secretion; this view is further supported 
by the fact that renal renin concentrations were 
significantly elevated in the 500-ppm rats. It 
has been reported that basal renin secretory 
rates and renal renin concentrations are well 
correlated in a variety of chronic physiologic 
states (Park et al., 1978). 
Rats exposed to 1000 ppm lead also had 
renin clearances that were not different from 
controls. However, unlike the 500-ppm rats, 
these animals also failed to exhibit an eleva- 
tion in plasma renin concentration. This find- 
ing is the first report of the effects of 1000 
ppm lead on renin, and the discrepancy be- 
tween the effects of 500 and 1000 ppm is con- 
sistent with our previous conclusions (Victery 
et al.. 1982b) that the dose-response relation- 
ship between lead and renin is complex, con- 
sisting of both inhibitory and stimulatory 
components. It is likely that at the lOOO-ppm 
dose these opposing effects tend to cancel each 
other out. This view is also consistent with 
our recent finding of increased basal renin se- 
cretion by renal cortical slices from rabbits 
exposed to 500 ppm Pb with no further aug- 
mentation at 1000 ppm Pb (Keiser et al., 
1983). 
The present model for studying renin clear- 
ance is the classic steady-stage metabolic 
clearance method, but it has not previously 
been reported for unanesthetized rats. Such a 
constant infusion technique should be more 
accurate for assessing the rate of renin re- 
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moval from plasma than are the more usual 
approaches involving disappearance curves 
following nephrectomy or bolus injections of 
renin. Moreover, we chose to use this un- 
anesthetized, unrestrained rat model to elim- 
inate the problems resulting from alterations 
in hepatic blood flow associated with anes- 
thetic agents and surgical trauma (Birnie and 
Grayson, 1952). Infusions of exogenous ho- 
mologous renin for an adequate length of time 
permit attainment of steady-stage conditions 
for the measurement of clearance. In pilot ex- 
periments with both BSP and renin infusions, 
steady-state plasma concentrations were 
achieved within 20 to 25 min. Therefore, renin 
clearance measurements in the present stud- 
ies were performed after at least 45 min of 
constant infusion. The stability of the clear- 
ance measurements at 45, 60, and 75 min 
after initiating renin infusions attests to the 
achievement of steady-state conditions. 
An important assumption in these experi- 
ments is that the infusions were the sole sig- 
nificant source of the test substances. Since 
BSP does not occur naturally in rats this cri- 
terion was readily met; however, renin is, of 
course, secreted by rats in response to a num- 
ber of stimuli, including hemorrhage. The 
chronic rats used in these experiments aver- 
aged 525 to 560 g, and the blood samples 
drawn during the course of a protocol totaled 
about 1.5 ml. Thus the blood sampling that 
occurred amounted to approximately a 5% 
hemorrhage over a 90-min interval. However, 
it is important to note that hematocrit did not 
change between the first and last samples, in- 
dicating the modest nature of this hemor- 
rhage. That endogenous renin is, in fact, not 
a problem in our methods is evidenced by the 
series of animls in which AI1 was infused. 
PRCs fell to very low values (2.1 f 0.7 ng/ 
ml/hr) despite the blood sampling that oc- 
curred, even though the final plasma AI1 con- 
centrations achieved by the AI1 infusions were 
only 50% of those produced by the infusions 
of renin. Thus, any remaining endogenous 
renin secretion must have been only a trivial 
percentage of the total renin infused per min- 
ute into the test rats (mean steady-state 
plasma renin achieved was approximately 100 
ng/ml/hr). 
A second potential problem with the pres- 
ent method is its use of exogenous rather than 
endogenous renin. However, it has been re- 
ported that endogenous and exogenous renin 
is inactivated at the same rate in both dogs 
(Schneider et al., 1968) and rats (Peters-Hae- 
feli, 197 1; Schaechtelin et al., 1964). 
Finally, it is crucial to ask whether the 
clearance rates at the PRC levels achieved 
during our infusions are an accurate reflection 
of the clearance of renin in the normal phys- 
iologic range of PRCs. In the group of rats in 
which the renin infusion dose was lowered by 
50%, PRCs averaged only 40 to 45 ng/ml/hr, 
but the clearance of renin was not different 
from rats with PRCs of 85 to 90 ng/ml/hr 
(series A) or PRCs of 120 to 130 ng/ml/hr 
(series B). These data suggest that the mass of 
renin cleared per unit time is a linear function 
of plasma concentration (i.e., clearance is 
constant) over a wide range of plasma con- 
centrations. 
The renin clearance rates measured in these 
experiments averaged 13 to 16 ml/kg/min. 
These values are threefold higher than those 
reported by Boyd (1979) and Peters-Haefeli 
( 197 1); however, it is important to note that 
both previous studies were performed on 
anesthetized rats after extensive surgery. The 
BSP clearances measured in our experiments 
provided a monitor for changes in hepatic 
blood flow, but without hepatic a-v differ- 
ences, actual flows could not be quantified. 
However, if a 50% value for the extraction of 
BSP is assumed (Bradley et al., 1945), the 
clearance data predict average hepatic plasma 
flows of 38 to 50 ml/kg/min. Hematocrits 
ranged from 40 to 45%, giving hepatic blood 
flows of 55 to 75 ml/kg/min. These are very 
similar to values reported by Birnie and Gray- 
son (1952) for unanesthetized rats. Again, as- 
suming 50% extraction for BSP and that the 
liver is the only significant source of renin 
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clearance, the ratio of BSP and renin clear- 
ances would yield an hepatic extraction ratio 
of 40% for renin, a value similar to that re- 
ported for rats (Horky et al., 1970) and other 
species (Heacox et al., 1967: Hesse er al.. 
1978). 
The 30% fall in BSP clearance observed in 
the chronic rats between 30 and 75 min is 
most likely due to the vasoconstrictor effects 
of large quantities of circulating AI1 on he- 
patic resistance vessels, rather than simply to 
a spontaneous change over time. In support 
of this, in experiments with normal rats that 
received only BSP for the entire 90-min pro- 
tocol, BSP clearances fell only 13 + 6% be- 
tween 30 and 75 min, whereas age-matched 
controls receiving both BSP and renin dem- 
onstrated a 3 1 ? 3% drop in the clearance of 
BSP during the same interval. BSP clearances 
did not continue to drop between 75 and 90 
min suggesting that the vasoconstriction had 
reached a steady state. A direct vasoconstric- 
tor effect of AI1 on hepatic resistance vessels 
has been demonstrated in dogs (DiSalvo et 
al., 1973). 
We have previously shown that acute iv 
administration of lead results in a dissociation 
of plasma AI1 and PRA (Goldman et al., 
198 1). If plasma AI1 levels failed to rise with 
increasing levels of PRA, this finding might 
explain the increased PRA observed with 500 
ppm lead; since AI1 is a inhibitor of renin 
secretion, inappropriately low plasma AI1 
concentrations at a given level of PRA would 
exert less inhibition on renin secretion, and 
both renin secretion and PRA would rise until 
a new steady state was achieved. However, 
there was no evidence for a decreased AII/ 
PRA ratio at 500 ppm lead in these experi- 
ments, as evidenced by the slope of the regres- 
sion line for AI1 and PRA in these animals 
and their controls. In contrast. the rats ex- 
posed to 1000 ppm lead did have a lower AII/ 
PRA ratio than either the control or .500-ppm 
rats. As previously suggested, this failure of 
AI1 to increase normally with PRA is due to 
a lead-induced inhibition of AI conversion to 
AND GERMAIN 
AI1 and/or an increased clearance of AI1 
(Goldman et al., 1981). Finally, it should be 
noted that this phenomenon occurs with much 
lower doses of lead when exposure to the metal 
is begun in utero (Victery et al., 1982b). 
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